These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Species-dependent differences of high affinity [3H]PAF-binding to platelets from humans and pigs and its inhibition by selected antagonists. Ostermann G; Lorenz A; Hofmann B; Kertscher HP J Lipid Mediat; 1991 Nov; 4(3):289-98. PubMed ID: 1662546 [TBL] [Abstract][Full Text] [Related]
25. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets. Suzuki M; Sugatani J; Ino M; Shimura M; Akiyama M; Yamazaki R; Suzuki Y; Miwa M Am J Physiol; 1998 Jan; 274(1):C47-57. PubMed ID: 9458712 [TBL] [Abstract][Full Text] [Related]
26. 1-O-hexadecyl-2-acetyl-sn-glycero-3-phospho (N,N,N trimethyl) hexanolamine: an analogue of platelet-activating factor with partial agonist activity. Grigoriadis G; Stewart AG Br J Pharmacol; 1991 Sep; 104(1):171-7. PubMed ID: 1664761 [TBL] [Abstract][Full Text] [Related]
27. Effects of Ro 24-4736 in antagonizing the platelet and bronchoconstrictor responses to PAF. O'Donnell M Ann N Y Acad Sci; 1991; 629():416-8. PubMed ID: 1659287 [No Abstract] [Full Text] [Related]
28. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor. Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914 [TBL] [Abstract][Full Text] [Related]
29. Partial agonist effect of the platelet-activating factor receptor antagonists, WEB 2086 and WEB 2170, in the rat perfused heart. Hu W; McNicholl IK; Choy PC; Man RY Br J Pharmacol; 1993 Oct; 110(2):645-50. PubMed ID: 8242237 [TBL] [Abstract][Full Text] [Related]
30. 1,4-Dihydropyridines, a new class of platelet-activating factor receptor antagonists: in vitro pharmacologic studies. Ortega MP; García MC; Gijón MA; de Casa-Juana MF; Priego JG; Sanchez Crespo M; Sunkel C J Pharmacol Exp Ther; 1990 Oct; 255(1):28-33. PubMed ID: 2170624 [TBL] [Abstract][Full Text] [Related]
31. The platelet activating factor receptor antagonist, RP 59227, blocks platelet activating factor receptors mediating liberation of reactive oxygen species in guinea pig macrophages and human polymorphonuclear leukocytes. Floch A; Tahraoui L; Sedivy P; Cavero I J Pharmacol Exp Ther; 1991 Aug; 258(2):567-75. PubMed ID: 1650834 [TBL] [Abstract][Full Text] [Related]
32. Platelet activating factor and sheep platelets: a sensitive new bioassay. Moon DG; van der Zee H; Morton KD; Krasodomski JA; Kaplan JE; Fenton JW Thromb Res; 1990 Feb; 57(4):551-64. PubMed ID: 2326773 [TBL] [Abstract][Full Text] [Related]
35. Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor. Casals-Stenzel J; Muacevic G; Weber KH J Pharmacol Exp Ther; 1987 Jun; 241(3):974-81. PubMed ID: 3598913 [TBL] [Abstract][Full Text] [Related]
36. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation. Ring PC; Seldon PM; Barnes PJ; Giembycz MA Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515 [TBL] [Abstract][Full Text] [Related]
37. A specific, photolabile and irreversible antagonist (L662,025) of the PAF-receptor. Hussaini IM; Shen TY Biochem Biophys Res Commun; 1989 May; 161(1):23-30. PubMed ID: 2543410 [TBL] [Abstract][Full Text] [Related]
38. The inhibition of platelet-activating factor-induced platelet activation by oleic acid is associated with a decrease in polyphosphoinositide metabolism. Nunez D; Randon J; Gandhi C; Siafaka-Kapadai A; Olson MS; Hanahan DJ J Biol Chem; 1990 Oct; 265(30):18330-8. PubMed ID: 2170407 [TBL] [Abstract][Full Text] [Related]
39. Effect of a Paf antagonist, WEB 2086, on airway microvascular leakage in the guinea-pig and platelet aggregation in man. Evans TW; Dent G; Rogers DF; Aursudkij B; Chung KF; Barnes PJ Br J Pharmacol; 1988 May; 94(1):164-8. PubMed ID: 3401633 [TBL] [Abstract][Full Text] [Related]
40. Ex vivo effects of SR 27417, a novel PAF antagonist, on rabbit platelet aggregation and [3H]-PAF binding. Herbert JM; Laplace MC; Maffrand JP J Lipid Mediat; 1992 Feb; 5(1):1-12. PubMed ID: 1327264 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]